YKL-40 and KL-6 in serum and sputum samples of patients diagnosed with hypersensitivity pneumonitis. Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases Year: 2019
Human napsin a is a useful serum marker of interstitial lung disease, compared to KL-6, and surfactant protein-D Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009
Comparative study of CC16, KL-6 and SP-D as serum markers in sarcoid patients Source: Eur Respir J 2002; 20: Suppl. 38, 173s Year: 2002
Elevated levels of serum SP-A in chronic eosinophilic pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 409s Year: 2001
Serum KL-6, SP-D and MMP-2 as diagnostic biomarkers in asbestosis and silicosis Source: International Congress 2017 – Silicosis has not gone away Year: 2017
Serum KL-6 level is increased in patients with pneumocystis pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 101s Year: 2006
The elevation serum napsin A in primary lung adenocarcinoma, compared with CEA Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012
Elevated serum S100A4 levels in patients with silicosis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019
Study of angiotensin-converting enzyme, serum amyloid A, soluble interleukin-2 receptor, lysozyme and KL-6 in serum as diagnostic markers in pulmonary sarcoidosis Source: Annual Congress 2007 - Sarcoidosis: various aspects Year: 2007
Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017
CEA levels in the serum and induced sputum of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005
Elevated levels of BALF galectin-9 in patients with interstitial pneumonia Source: Annual Congress 2009 - Airways remodelling Year: 2009
Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011
High serum levels of YKL-40 in IPF Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008
Pulmonary tumour with high carcinoembryonic antigen titre caused by chronic propolis aspiration Source: Eur Respir J 2007; 30: 1227-1230 Year: 2007
The clinical significance of serum osteoprotegerin (OPG) and pro-gastrin-releasing peptide (ProGRP) concentrations in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 318s Year: 2004
Bio-markers (KL-6, SP-D and SP-A) in drug-induced pneumonitis Source: Eur Respir J 2002; 20: Suppl. 38, 59s Year: 2002
KL-6/MUC1 in interstitial pneumonia Source: Annual Congress 2005 - Lung-specific serum markers for interstitial lung diseases Year: 2005
Serum KL-6 as a marker of disease progression in SSc-ILD Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018
Circadian variations in serum eosinophil cationic protein (ECP), and serum and urine eosinophil protein X (EPX) in children Source: Eur Respir J 2001; 18: Suppl. 33, 451s Year: 2001